Search research articles
Contact Us
Filters
Showing results (371-380 of 433) with videos related to
Page
of 44
Sort By:
Oncotarget
|
April 2, 2016
Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53
Twishasri DasGupta, Emeka I Nweze, Hong Yue, et al.
JAMA Dermatology
|
February 16, 2017
Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial
Joselin D Tacastacas, Derek V Chan, Sean Carlson, et al.
Molecular Immunology
|
December 25, 2021
Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2)
David C Soler, Amber Kerstetter-Fogle, Andrew B Young, et al.
The British Journal of Dermatology
|
April 23, 2010
Malignant T cells in cutaneous T-cell lymphoma lesions contain decreased levels of the antiapoptotic protein Ku70
K Ferenczi, J Ohtola, P Aubert, et al.
Antibiotics (Basel, Switzerland)
|
August 29, 2020
Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of <i>Candida auris</i> Infections
Mahmoud Ghannoum, Maiken Cavling Arendrup, Vishnu P Chaturvedi, et al.
Ebiomedicine
|
November 25, 2024
NF-κB c-Rel is a critical regulator of TLR7-induced inflammation in psoriasis
Angela Rose Liu, Nandini Sarkar, Jordan D Cress, et al.
Clinical and Experimental Dermatology
|
June 1, 2011
Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy
M Lam, A H Hsia, Y Liu, et al.
The Journal of Investigative Dermatology
|
September 28, 2017
Protection from Psoriasis-Related Thrombosis after Inhibition of IL-23 or IL-17A
Yumeng Li, Jackelyn B Golden, Maya I Camhi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 30, 2013
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation
Andrew Johnston, Yi Fritz, Sean M Dawes, et al.
Leukemia
|
July 29, 2005
Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics
C G Cerveny, C-L Law, R S McCormick, et al.
Page
of 44
Search research articles
Search
Showing results (371-380 of 433) with videos related to
Sort By:
Page
of 44
Oncotarget
|
April 2, 2016
Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53
Twishasri DasGupta, Emeka I Nweze, Hong Yue, et al.
JAMA Dermatology
|
February 16, 2017
Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial
Joselin D Tacastacas, Derek V Chan, Sean Carlson, et al.
Molecular Immunology
|
December 25, 2021
Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2)
David C Soler, Amber Kerstetter-Fogle, Andrew B Young, et al.
The British Journal of Dermatology
|
April 23, 2010
Malignant T cells in cutaneous T-cell lymphoma lesions contain decreased levels of the antiapoptotic protein Ku70
K Ferenczi, J Ohtola, P Aubert, et al.
Antibiotics (Basel, Switzerland)
|
August 29, 2020
Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of <i>Candida auris</i> Infections
Mahmoud Ghannoum, Maiken Cavling Arendrup, Vishnu P Chaturvedi, et al.
Ebiomedicine
|
November 25, 2024
NF-κB c-Rel is a critical regulator of TLR7-induced inflammation in psoriasis
Angela Rose Liu, Nandini Sarkar, Jordan D Cress, et al.
Clinical and Experimental Dermatology
|
June 1, 2011
Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy
M Lam, A H Hsia, Y Liu, et al.
The Journal of Investigative Dermatology
|
September 28, 2017
Protection from Psoriasis-Related Thrombosis after Inhibition of IL-23 or IL-17A
Yumeng Li, Jackelyn B Golden, Maya I Camhi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 30, 2013
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation
Andrew Johnston, Yi Fritz, Sean M Dawes, et al.
Leukemia
|
July 29, 2005
Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics
C G Cerveny, C-L Law, R S McCormick, et al.
Page
of 44